Clinical trial
Local Registration Trial in China Humalog Mix 50
NCT00191581 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00191581 |
|---|---|
| Title | Local Registration Trial in China Humalog Mix 50 |
| Official title | Comparison of 2-Hour Postprandial Blood Glucose Excursion in Response to a Standard Test Meal in Insulin-Requiring Diabetic Patients Treated Twice Daily With Either Insulin Lispro Mix 50/50 or Human Insulin Mix 50/50 |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 1, Type 2 |
| Intervention type | Drug |
| Interventions | Humalog Mix 50, Human Insulin Mix 50:50 |
| Enrollment | 120 |
| Start date | Mar 1, 2005 |
| Completion | Apr 1, 2006 |
| First posted | Sep 19, 2005 |
| Last update posted | Jul 31, 2006 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: